PRESS RELEASE published on 11/27/2025 at 11:00, 8 months 2 days ago Temas Completes Drill Program Targeting Critical Minerals and Rare Earth Elements Temas Resources Corp. completes successful HQ diamond drilling at La Blache Vanadium Titanomagnetite Critical Mineral Project in Quebec, Canada, exploring Rare Earth Elements and patented Regenerative Chloride Leach technology Rare Earth Elements Temas Resources Corp. La Blache Regenerative Chloride Leach Technology HQ Diamond Drilling
PRESS RELEASE published on 11/27/2025 at 10:35, 8 months 2 days ago Rising Holiday Production Drives Demand for Monport Laser Engraving Machines Across Germany Monport Laser experiences increased demand for laser engraving machines in Germany amid rising holiday production, offering major savings and expanded bundles to meet customer needs Savings Germany Monport Laser Laser Engraving Machines Holiday Production
PRESS RELEASE published on 11/27/2025 at 10:05, 8 months 2 days ago NAVIGATING A MULTIPOLAR WORLD: GLOBAL LEADERS GATHER IN PARIS Paris to host the 9th Conference of Paris organized by IEFA on Dec 16-17, 2025, addressing global challenges in sustainable finance, AI, energy transition, and more Global Challenges Sustainable Finance Industrial Sovereignty Conference Of Paris IEFA
PRESS RELEASE published on 11/27/2025 at 10:05, 8 months 2 days ago Farizon Establishes European Spare Parts Warehouse, Opening a New Chapter in European Logistics Farizon New Energy Commercial Vehicle Group, Duvenbeck Logistics Group, and AGN LEANWAY International Logistics Co. Ltd sign strategic cooperation agreement to establish a Farizon spare parts warehouse in Europe, enhancing logistics operations Strategic Cooperation European Logistics Farizon Spare Parts Warehouse Logistics Operations
PRESS RELEASE published on 11/27/2025 at 10:05, 8 months 2 days ago European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia granted Orphan Drug Designation by EMA, highlighting commitment to rare disease innovation Orphan Drug Designation Rare Disease Kedrion Plasma-derived Treatment Congenital Aceruloplasminemia
PRESS RELEASE published on 11/27/2025 at 10:00, 8 months 2 days ago Asklepios Group: Solid third quarter of 2025 – successful placement of Social Schuldschein loan strengthens financing basis Asklepios Group reports solid third quarter results in 2025, with a 6.3% increase in patient numbers and successful placement of a Social Schuldschein loan, strengthening financing basis Financing 2025 Asklepios Group Third Quarter Social Schuldschein Loan
PRESS RELEASE published on 11/27/2025 at 09:45, 8 months 2 days ago Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice Protagenic Therapeutics, Inc. receives notice of non-compliance with Nasdaq Listing Rules, takes steps for delisting appeal. Stock to continue trading during the process Nasdaq Listing Stock Trading Delisting Non-Compliance Protagenic Therapeutics
PRESS RELEASE published on 11/27/2025 at 09:10, 8 months 2 days ago Turkiye Garanti Bankasi A.S.: Dates on which the Trading Lines of Investment Institution Warrants Will Be Closed Due to Foreign Public Holidays Turkiye Garanti Bankasi A.S. announces the closure dates of investment institution warrants trading lines due to foreign public holidays on November 27, 2025 Turkiye Garanti Bankasi Investment Institution Warrants Trading Lines Public Holidays Closure Dates
PRESS RELEASE published on 11/27/2025 at 09:05, 8 months 2 days ago Highgrove and Cotswolds Distillery unveil "Highgrove Evergreen" - a tribute to the English countryside Highgrove and Cotswolds Distillery introduce 'Highgrove Evergreen' English Whisky crafted from Plumage Archer barley matured in Bourbon and STR red wine casks. Celebrates nature and heritage Craftsmanship English Whisky Cotswolds Distillery Plumage Archer Barley Highgrove
PRESS RELEASE published on 11/27/2025 at 09:05, 8 months 2 days ago €4m in 30 days: Bizcap's German expansion sets new benchmark Bizcap's German expansion into SME funding surpasses €4 million mark in first month, showcasing strong partnerships and market fit Partnerships Bizcap SME Funding German Expansion Market Fit
Published on 07/30/2026 at 04:10, 3 hours 46 minutes ago Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer
Published on 07/30/2026 at 01:50, 6 hours 6 minutes ago Further Assays Infill Tunkillia Pit Extension Targets
Published on 07/30/2026 at 00:50, 7 hours 6 minutes ago Aton Announces Strategic Cooperation Relationship and Board Nominee
Published on 07/30/2026 at 00:00, 7 hours 56 minutes ago American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026
Published on 07/29/2026 at 23:01, 8 hours 55 minutes ago Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Published on 07/30/2026 at 07:30, 25 minutes ago Erste Group: Strong operating performance, strategic progress in Poland
Published on 07/30/2026 at 07:30, 26 minutes ago ANDRITZ continues strong performance in the first half of 2026
Published on 07/30/2026 at 07:30, 26 minutes ago REINET INVESTMENTS S.C.A. ANNOUNCES COMPLETION OF SHARE BUYBACK PROGRAMME
Published on 07/30/2026 at 07:30, 26 minutes ago Drägerwerk AG & Co. KGaA: Dräger with strong business performance in the first half of 2026
Published on 07/30/2026 at 07:30, 26 minutes ago TAKKT continues stabilization trend amid volatile market conditions
Published on 07/30/2026 at 07:30, 26 minutes ago Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 56 minutes ago Mersen 2026 guidance raised after strong momentum in the first half
Published on 07/29/2026 at 23:00, 8 hours 56 minutes ago BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Published on 07/29/2026 at 18:40, 13 hours 15 minutes ago Aéroports de Paris SA - Availability of the 2026 financial interim report